Home Respiratory IPRAKAS L 1.25 RESP
FLUTIKASP S 250 ROTACAP Back to Respiratory IPRAKAS L INH
IPRAKAS L 1.25 RESP
LIVE_SCAN
QUALITY_SYSTEM: ACTIVE BATCH_VERIFIED: YES

IPRAKAS L 1.25 RESP

RESPULES REF: IPRAKAS_L_1.25_RESP
MRP Discount Selling Price You Saved
₹ 24.00 0% ₹ 24.00 ₹ 0.00
Accepted files: PDF, JPG, PNG. Mandatory for regulatory records compliance.
PCODE 443
SALT COMPOSITION LEVOSALBUTAMOL 1.25MG+IPRATROPIUM BROMIDE 500MCG RESPULES
TYPE RESPULES
PACKED IN RESPULES
PACKING 8X5X2.5ML
THERAPEUTIC RESPIRATORY
MAIN CATEGORY Respiratory & Allergy
PARENT MANUFACTURER HEALTHCARE

Product Overview

PHARMA INTEGRITY PROTOCOL

The Generic Advantage

Slide to visualize how artificial markups inflate branded medicine pricing, or compare the clinical facts below.

Interactive Cost Breakdown Simulator

Generic formulation Branded medicine
Direct Sourcing (Save up to 90%) Commercial Overhead & Markups
Active Ingredients & Mfg. ₹10
Estimated Patient Cost: ₹10
GENERIC_PROTOCOL_ACTIVE (100% Value)
RECOMMENDED PROTOCOL

Generic Medicines

₹10 avg. patient cost
  • ✓
    Active Ingredients: 100% Identical formula & strength
  • ✓
    Bioequivalence: Identical therapeutic effect & absorption
  • ✓
    Manufacturing: WHO-GMP / FDA Certified Plants
  • ✓
    Government Endorsed: PMBJP / Jan Aushadhi Approved
  • ✓
    Supply-Chain Savings: 80% to 90% Direct Sourced Discount
VS
RETAIL STANDARD

Branded Medicines

₹100 avg. patient cost
  • ✓
    Active Ingredients: 100% Identical formula & strength
  • ✓
    Bioequivalence: Identical therapeutic effect & absorption
  • ✓
    Manufacturing: WHO-GMP / FDA Certified Plants
  • ✗
    Commercial Markup: Up to 800% marketing & ad inflation
  • ✗
    Patient Burden: Full brand premium pricing
Understand B2C Ordering Protocols →

You may also like

Recently viewed products